Back to top

earnings-consensus: Archive

Zacks Equity Research

OceanFirst Financial (OCFC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

OceanFirst (OCFC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OCFCNegative Net Change

Zacks Equity Research

McCormick (MKC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

McCormick (MKC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MKCNegative Net Change

Zacks Equity Research

Sallie Mae (SLM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Sallie Mae (SLM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SLMNegative Net Change

Zacks Equity Research

ACNB (ACNB) to Report Q4 Results: Wall Street Expects Earnings Growth

ACNB (ACNB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ACNBNegative Net Change BANCNegative Net Change

Zacks Equity Research

GE Aerospace (GE) Earnings Expected to Grow: Should You Buy?

GE (GE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GEPositive Net Change

Zacks Equity Research

Freeport-McMoRan (FCX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Freeport-McMoRan (FCX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FCXNegative Net Change

Zacks Equity Research

Analysts Estimate CSX (CSX) to Report a Decline in Earnings: What to Look Out for

CSX (CSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CSXNegative Net Change

Zacks Equity Research

Eastern Bankshares, Inc. (EBC) Earnings Expected to Grow: Should You Buy?

Eastern Bankshares (EBC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

EBCNegative Net Change EQBKNegative Net Change

Zacks Equity Research

Wall Street Analysts Think K12 (LRN) Could Surge 49.19%: Read This Before Placing a Bet

The consensus price target hints at a 49.2% upside potential for K12 (LRN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

LRNNegative Net Change

Zacks Equity Research

How Much Upside is Left in Immunovant (IMVT)? Wall Street Analysts Think 47.39%

The mean of analysts' price targets for Immunovant (IMVT) points to a 47.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

IMVTPositive Net Change

Zacks Equity Research

Wall Street Analysts Think Day One Biopharmaceuticals (DAWN) Could Surge 107.36%: Read This Before Placing a Bet

The mean of analysts' price targets for Day One Biopharmaceuticals (DAWN) points to a 107.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

DAWNNegative Net Change

Zacks Equity Research

Does KalVista Pharmaceuticals (KALV) Have the Potential to Rally 117.98% as Wall Street Analysts Expect?

The mean of analysts' price targets for KalVista Pharmaceuticals (KALV) points to an 118% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

KALVNegative Net Change

Zacks Equity Research

Wall Street Analysts See a 28.45% Upside in Marex Group PLC (MRX): Can the Stock Really Move This High?

The average of price targets set by Wall Street analysts indicates a potential upside of 28.5% in Marex Group PLC (MRX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

MRXPositive Net Change

Zacks Equity Research

Pinnacle Financial (PNFP) Earnings Expected to Grow: Should You Buy?

Pinnacle Financial (PNFP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PNFPPositive Net Change HWCNegative Net Change

Zacks Equity Research

Banc of California (BANC) Earnings Expected to Grow: Should You Buy?

Banc of California (BANC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BANCNegative Net Change BOKFPositive Net Change

Zacks Equity Research

Dime Community (DCOM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Dime Community (DCOM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DCOMNegative Net Change SFNCNegative Net Change

Zacks Equity Research

Equity Bancshares (EQBK) Earnings Expected to Grow: Should You Buy?

Equity Bancshares (EQBK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

EQBKNegative Net Change OZKNegative Net Change

Zacks Equity Research

Truist Financial Corporation (TFC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Truist Financial (TFC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TFCNegative Net Change FITBPositive Net Change

Zacks Equity Research

Earnings Preview: Travelers (TRV) Q4 Earnings Expected to Decline

Travelers (TRV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TRVNegative Net Change

Zacks Equity Research

Ally Financial (ALLY) Earnings Expected to Grow: Should You Buy?

Ally Financial (ALLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ALLYNegative Net Change

Zacks Equity Research

Live Oak Bancshares (LOB) Earnings Expected to Grow: Should You Buy?

Live Oak Bancshares (LOB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LOBNegative Net Change

Zacks Equity Research

Old National Bancorp (ONB) Earnings Expected to Grow: Should You Buy?

Old National Bancorp (ONB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ONBNegative Net Change WTFCNegative Net Change

Zacks Equity Research

Teledyne Technologies (TDY) Earnings Expected to Grow: Should You Buy?

Teledyne (TDY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TDYPositive Net Change

Zacks Equity Research

Johnson & Johnson (JNJ) Reports Next Week: Wall Street Expects Earnings Growth

Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

JNJNegative Net Change

Zacks Equity Research

Knight-Swift Transportation Holdings (KNX) Reports Next Week: What to Know Ahead of the Release

Knight-Swift (KNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

KNXNegative Net Change